Screen Pharma Screen Drug Test Ecstasy

Instructions for use for each test combination of the following drugs: amphetamine, benzodiazepine, cocaine, marijuana, methyldioxymethamphetamine, ketamine, opiates, synthetic k2 / spice marijuana.
One-step test for the simultaneous qualitative determination of drugs and their metabolites in human urine.

Precautions
Product not intended for medical or diagnostic use.
Do not use beyond the expiration date.
Store the test strip panel in the closed pouch until ready for use.
All samples must be considered potentially dangerous and therefore, must be handled with the precautions for use relating to potentially infectious products.
After use, the panel must be disposed of according to local regulations in force.
Store in the sealed packaging at a temperature between 2 ° and 30 ° C.
The test strip panel is stable until the expiration date indicated on the package label.
The test strip panel should be kept in the sealed pouch until use.
Do not freeze.
Do not use beyond the expiration date.

Intended Use and Summary
Screening test for the simultaneous determination of several drugs.
The speed and sensitivity of immunological tests have led them to be considered the most accepted as a urine screening test for the simultaneous research of drugs of abuse.
The Single Step Test Strip Brush (Urine) is a rapid lateral flow immunochromatographic test for the qualitative determination of the following drugs without the aid of tools:

Test	Calibrator	Cut-off (ng / ml)
Cocaine (COC) Amphetamine (AMP) Methyldioxymethhamphetamine (MDMA) Marijuana (THC) Opiates (OPI) Benzodiazepine (BZO) Ketamine (KET) Synthetic marijuana k2 / spice	benzolecnogina d-amphetamine d, 1-methyldioxymethamphetamine 11-nor-Δ 9 -THC-9 COOH morphine Oxazepam Ketamine jwh-018 and jwh-073	300 1000 500 50 2000 300 1000 50

This test provides preliminary analytical data only.
More specific chemical methods should be used as confirmation of the analytical result.
Gas chromatography and mass spectrometry (GC / MS) are considered to be preferred confirmatory methods.
Any drug of abuse determination result must have correlated with clinical considerations and professional judgment, particularly when the preliminary result is positive.
It is a rapid urine screening test that does not require the use of special tools.
The test uses antibodies to selectively detect high levels of specific substances in human urine.

The residence times are approximate for each substance as they vary according to the frequency of use, body mass, age, state of health, tolerance to drugs and the pH of the urine.
The product detects the presence of narcotic substances in the urine only after their metabolization.

COCAINE (COC)
Cocaine is a potent central nervous system stimulant as well as a local anesthetic derived from the coca plant.
The substance is often self-administered by inhalation or intravenous injection or by smoking the base substance.

AMPHETAMINE (AMP)
Amphetamine is a substance also used for therapeutic purposes.
The substance is often self-administered by inhalation or ingestion.
High doses produce enhanced central nervous system stimulation and induce euphoria, alertness, decreased appetite, a sense of increased energy and strength.
More acute reactions produce anxiety, paranoia, hallucinations and psychotic behavior.

METHYLDIOXYMETHAMPHETAMINE (MDMA)
Ecstasy is not a stimulant, although it has the ability to increase blood pressure and heart rate in common with amphetamines.
It produces some perception changes such as increased sensitivity to light, difficulty focusing, blurred vision.
The effect that occurs practically in all those who take this substance is to make the jaw clench.

MARIJUANA (THC)
Tetrahydrocannabinol is the active ingredient in cannabis.
When smoked or taken orally, THC produces euphoria.
Regular users have short-term memory impairment and learning delays, they may also have transient episodes of confusion and anxiety.
Relatively heavy long-term consumption may be associated with behavioral disturbances.

OPIASES (OPI)
The class of opiates refers to any substance derived from the opium poppy, including natural compounds such as morphine, codeine and semi-synthetic substances such as heroin.
Opiates act on pain control by depressing the central nervous system.
Withdrawal symptoms can include sweating, tremors, nausea, and irritability.
Opiates can be taken orally or by intravenous, intramuscular and subcutaneous injection.
Consumers can also take the substance intravenously or by inhalation.

BENZODIAZEPINE (BZO)
They are frequently prescribed drugs for the symptomatic treatment of anxiety, sleep disturbances, seizures and alcohol withdrawal syndrome.
Stopping abruptly can induce symptoms such as sleep disturbances, gastrointestinal disturbances, loss of appetite, sweating, tremor, weakness, anxiety, and changes in perception.

KETAMINA (KET)
Ketamine is a dissociative anesthetic for human and veterinary use.
It is marketed in Italy under the names of Ketalar, Ketanest and Ketaset and in the human context it is classified as Drug "H" and should be used exclusively in a hospital setting by an anesthetist-resuscitator.
Like all neuro and psycholactic drugs, they can be abused and used as a luxury drug, prohibited and sanctioned by the law, as a narcotic substance.

MARIJUANA SYNTHETIC K2 / SPICE (K2 / SPICE)
Synthetic Marijuana or K2 is a psychoactive herb and chemical that when consumed mimics the effects of Marijuana.
Mostly known by the trade names of K2 and Spice, both of which are widely used to refer to any synthetic Marijuana product.

Principle
The One Step Test Strip Panel (Urine) is a rapid immunochromatographic test based on the principle of competitive binding.
Drugs that may be present in the urine specimen compete with its conjugate for the same binding sites as the antibody.
During the test, a urine sample migrates by capillarity along the membrane.
A drug, if present in the urine sample, at a concentration below the propriocut-off, will not be able to saturate all the binding sites of the particles bound to the relative antibodies present in the strip.
The particles bound to the antibodies will be captured by the immobilized conjugate and a visible colored band will appear in the test band area of the relevant strip.
The colored band will not form in the relevant area if the drug level is above its cut-off, as all binding sites of the relevant antibodies will be saturated.
A urine specimen positive for the test drug will not cause the color band to form due to drug competition, while a urine specimen negative for the test drug or a specimen containing a concentration of the drug below the cut-off will cause the band to form. colored in the test specification.
As a control of the procedure, a colored band will appear in the relevant area, indicating that a correct amount of sample has been used and that migration on the membrane has occurred.

Reagents
Each strip of the panel contains mouse monoclonal antibodies bound to the particles and to the corresponding one.
The One Step Test Strip Panel (Urine) is a conjugated lateral flow immunochromatographic rapid test for each drug.
Goat antibodies are used for the control band.

Sample collection and preparation
Collect the urine sample in a clean, dry container.
Urine samples collected at any time of the day can be used.
Urine specimens with evident precipitates should be centrifuged, filtered, or allowed to settle in order to obtain a clear specimen for testing.
Urine samples can be stored at 2-8 ° C for up to 48 hours.
For extended storage, samples can be frozen and stored below -20 ° C.
Before using frozen samples, they must be thoroughly thawed and homogenized.

Procedure of use
1. Before opening the package, bring it to room temperature. Take the product out of the package and use it as soon as possible.
2. Remove the cap from the strips. Immerse the product vertically, in the direction of the arrows, in the urine sample for at least 10/15 seconds. Dip the product up to the level of the wavy lines on the strips but not above them.
3. Put the cap back on the device and lay the product horizontally on a flat non-absorbent surface. Read the result after 5 minutes. Do not interpret the result after 10 minutes.

Interpretation of results
Negative *: One colored band appears in the control region (C) and a second one in the test region (T) for each drug indicating a negative result.
This negative result indicates that the concentration of the target drug in urine is below the detectable cut-off level for that specific drug.
* the color tone in the reactive zone (T) may vary, but must be considered negative whenever a faint color band appears.
Positive: A colored band appears in the control zone (C) but not in the reactive zone (T) for each drug indicating a positive result.
The positive result indicates that the concentration of the target drug in urine is above the detectable cut-off level for that specific drug.
Invalid: the control band (C) does not appear.
The most plausible causes for the missing control band may be insufficient sample volume or incorrect analytical procedure.
Check the procedure again and repeat the test using a new panel.
If the problem persists, stop using the kit immediately and contact your local distributor.
If the test is positive, avoid aggressive behavior and calmly seek a dialogue with the person concerned.
Get advice from your doctor, a psychologist or contact the competent service for your area.

Quality control
The test includes an internal control system consisting of the red band appearing in the control region (C).
The appearance of this band confirms that the test was performed correctly with sufficient sample volume, that the membrane absorption was adequate and the procedure was correct.
Standard controls are not supplied with the kit; however, it is recommended to test positive and negative controls, as a good laboratory practice, to confirm the test procedure and verify the correct characteristics.

Limits
1. The One Step Test Strip Panel (Urine) provides a qualitative preliminary analytical result only. A second analytical method is required. Preferred confirmatory methods are gas chromatography and mass spectrometry (GC / MS) are the recommended confirmatory methods if the test is positive.
2. It is possible that technical or procedural errors, as well as interfering substances in the urine sample, could cause erroneous results.
3. It is possible that adulterants such as bleach and / or alum present in the urine sample may cause erroneous results regardless of the analytical method used. If such substances are suspected, the test should be repeated with another urine sample.
4. A positive result indicates the presence of the drug or its metabolites but not the level of intoxication, route of administration or concentration in urine.
5. A negative result does not necessarily mean that the urine sample is drug-free. A negative result may be obtained when the drug is present but below the cut-off level of the test.
6. The test cannot distinguish between a drug and a drug containing the same substance. False positives may be caused by some drugs.

Format
• 1 urine container.
• 1 Cocaine Test Drug.
• package leaflet.